Lytix Biopharma as

Last updated September 27, 2026

Organization details

Legal name
Lytix Biopharma as
Also known as (brands, DBAs, abbreviations)
Lytix Biopharma
Ownership
Public
Status
Active
Headquarters city
Oslo
Headquarters country
Norway
Ticker symbol
LYTIX
Primary stock exchange
Euronext

Identifiers

LEI
549300NXMIMRSBCDZO71
ISIN
NO0010405780
Norwegian organization number
985889635

Board of directors

Chief executives

Øystein Rekdal · Chief executive (daglig leder)
Dates unknown

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.